FTS BIO LIMITED

Active Newcastle Upon Tyne

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goodsWholesale of chemical products +1
F

FTS BIO LIMITED

Wholesale of pharmaceutical goods

Founded 25 Mar 2013 Active Newcastle Upon Tyne, United Kingdom 0 employees website.com
Wholesale of pharmaceutical goodsWholesale of chemical productsOther business support service activities n.e.c.
Accounts Submitted 19 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 25 Mar 2026 Next due 2 Apr 2027 10 months remaining
Net assets £361 £0 2024 year on year
Total assets £371 £0 2024 year on year
Total Liabilities £10 £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

5 Osborne Terrace Jesmond Newcastle Upon Tyne NE2 1SQ

Full company profile for FTS BIO LIMITED (08459176), an active company based in Newcastle Upon Tyne, United Kingdom. Incorporated 25 Mar 2013. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£371.00

Net Assets

£361.00

Total Liabilities

£10.00

Turnover

N/A

Employees

N/A

Debt Ratio

3%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Owen, Nicholas David Sutherland, DrDirectorBritishEngland6231 Jan 2019Active

Shareholders

Shareholders (2)

Fast Track Sourcing Limited
90.0%
Geoffrey Michael Porritt
10.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

FTS BIO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Mar 2026Confirmation StatementConfirmation statement made on 19 Mar 2026 with updates
19 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
19 Mar 2025Confirmation StatementConfirmation statement made on 19 Mar 2025 with no updates
7 Aug 2024AccountsAnnual accounts made up to 31 Mar 2024
9 Apr 2024OfficersChange to director Mr William Alasdair Gray on 1 Jul 2022
25 Mar 2026 Confirmation Statement

Confirmation statement made on 19 Mar 2026 with updates

19 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

19 Mar 2025 Confirmation Statement

Confirmation statement made on 19 Mar 2025 with no updates

7 Aug 2024 Accounts

Annual accounts made up to 31 Mar 2024

9 Apr 2024 Officers

Change to director Mr William Alasdair Gray on 1 Jul 2022

Recent Activity

Latest Activity

Confirmation statement made on 19 Mar 2026 with updates

2 months ago on 25 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 19 Dec 2025

Confirmation statement made on 19 Mar 2025 with no updates

1 years ago on 19 Mar 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 7 Aug 2024

Change to director Mr William Alasdair Gray on 1 Jul 2022

2 years ago on 9 Apr 2024